|
Insulin Clinical Trials
10 actively recruiting trials across 5 locations
No change since June 2026
Also known as: Humalog, Hyperinsulinemic euglycemic clamp, Lantus, Levemir, Lispro +1 more
Pipeline
Phase 2: 1Phase 4: 4Phase 2/3: 1
Top Sponsors
- Thomas Jefferson University2
- Ohio State University2
- University of Virginia1
- University of Copenhagen1
- Nanjing Medical University1
Indications
- Diabetes9
- Gestational Diabetes3
- Pregnancy, High Risk2
- Pregnancy Related2
- Ketosis Prone Diabetes1
Other4 trials
Rochester, New York2 trials
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes
University of Rochester Medical Center
N/A
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
University of Rochester Medical Center
N/A
Tuscaloosa, Alabama1 trial
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
University of Alabama
Phase 4
Atlanta, Georgia1 trial
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Grady Health System
Phase 4
Columbus, Ohio1 trial
Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Phase 4
Charlottesville, Virginia1 trial
GDM: Insulin with or Without Metformin?
University of Virginia
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.